Plasmodium falciparum Variant Surface Antigen Expression Patterns during Malaria by Bull, Peter C et al.
Plasmodium falciparum Variant Surface
Antigen Expression Patterns during Malaria
Peter C. Bull
1,2*, Matthew Berriman
3[, Sue Kyes
1[, Michael A. Quail
3, Neil Hall
4, Moses M. Kortok
2, Kevin Marsh
1,2,
Chris I. Newbold
1
1 Nuffield Department of Clinical Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom, 2 Wellcome Trust/Kenya Medical Research Institute
Collaborative Programme, Kilifi, Kenya, 3 Wellcome Trust Sanger Institute, Hinxton, United Kingdom, 4 The Institute for Genomic Research, Rockville, Maryland, United States
of America
The variant surface antigens expressed on Plasmodium falciparum–infected erythrocytes are potentially important
targets of immunity to malaria and are encoded, at least in part, by a family of var genes, about 60 of which are present
within every parasite genome. Here we use semi-conserved regions within short var gene sequence ‘‘tags’’ to make
direct comparisons of var gene expression in 12 clinical parasite isolates from Kenyan children. A total of 1,746 var
clones were sequenced from genomic and cDNA and assigned to one of six sequence groups using specific sequence
features. The results show the following. (1) The relative numbers of genomic clones falling in each of the sequence
groups was similar between parasite isolates and corresponded well with the numbers of genes found in the genome
of a single, fully sequenced parasite isolate. In contrast, the relative numbers of cDNA clones falling in each group
varied considerably between isolates. (2) Expression of sequences belonging to a relatively conserved group was
negatively associated with the repertoire of variant surface antigen antibodies carried by the infected child at the time
of disease, whereas expression of sequences belonging to another group was associated with the parasite ‘‘rosetting’’
phenotype, a well established virulence determinant. Our results suggest that information on the state of the host–
parasite relationship in vivo can be provided by measurements of the differential expression of different var groups,
and need only be defined by short stretches of sequence data.
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Introduction
In sub-Saharan Africa, Plasmodium falciparum malaria
infection is a major cause of childhood mortality. Adults,
though still susceptible to infection, are protected against
severe forms of malaria. Despite considerable attention over
the last decade, this naturally acquired immunity is poorly
understood at the molecular level. Even less understood is
why, despite similar exposure levels, some children get severe
malaria and die whereas others never succumb to life-
threatening disease. Molecular tools to type infecting para-
sites and to give meaningful information about the host–
parasite interaction in vivo are needed urgently.
P. falciparum erythrocyte membrane protein 1 (PfEMP1)
plays a central role in the host–parasite interaction. Members
of this family of molecules are inserted into the surface of
infected erythrocytes by parasites during the asexual stage of
growth. PfEMP1 molecules are encoded by a family of about
60 highly diverse var genes [1] that undergo rapid switching in
vitro and are thought to be largely responsible for the well
characterized phenomenon of clonal antigenic variation [2–
5]. In addition, they appear to be central to changes in
cytoadherence properties that lead to the sequestration of
infected erythrocytes in capillary beds, potentially a key step
in the pathology of severe disease [6,7]. The molecules are
made up of combinations of different domains, each
mediating a speciﬁc range of interactions with molecules on
host endothelial cells [8–10], platelets [11], uninfected
erythrocytes [12,13], and dendritic cells [14].
PfEMP1 proteins are presently the best candidates for the
variant surface antigens (VSAs) proposed as targets for
naturally acquired immunity to malaria [15]. Following acute
disease, children develop speciﬁc immune responses to the
repertoire of VSAs that caused the infection. The anti-VSA
antibodies carried by the host at the time of disease impose a
selection pressure on the repertoire of VSAs expressed
during an infection [16–18]. Thus, naturally acquired im-
munity may develop through the piecemeal acquisition of a
large repertoire of anti-VSA antibodies [16]. This is
supported by the demonstration that PfEMP1-based vaccines
provide protection against experimental infection with a
speciﬁc parasite genotype [19].
PfEMP1 proteins have generally been considered to be too
diverse to be of use in a malaria vaccine. This diversity appears
to be generated, at least in part, by intragenic recombination
between var genes [20,21], raising fears that it may be
impossible to classify these genes in any meaningful sense.
However, other observations suggest this diversity may be
ﬁnite. First, VSAs expressed in children with severe malaria
show evidence of having restricted diversity. Parasite isolates
from children are recognised at different frequencies by
Received May 31, 2005; Accepted October 11, 2005; Published November 18, 2005
DOI: 10.1371/journal.ppat.0010026
Copyright:  2005 Bull et al. This is an open-access article distributed under the
terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author
and source are credited.
Abbreviations: CIDR, cysteine-rich interdomain region; DBL, Duffy-binding-like;
PfEMP1, Plasmodium falciparum erythrocyte membrane protein 1; PoLV, position of
limited variation; VSA, variant surface antigen
Editor: Barbara Burleigh, Harvard School of Public Health, United States of America
* To whom correspondence should be addressed. E-mail: pbull@kilifi.mimcom.net
[ These authors contributed equally to this work.
PLoS Pathogens | www.plospathogens.org November 2005 | Volume 1 | Issue 3 | e26 0202plasma collected from the childhood population in the same
geographical location. This frequency of recognition [17,22] is
dependent on the immune status of the host, being negatively
associated with host age and positively associated with disease
severity [17,18,22,23]. Commonly recognised VSAs also appear
to have a broad geographical distribution [24]. Second,
complete genome sequencing of laboratory P. falciparum line
3D7 [1] revealed genetic structuring of the var repertoire
within the genome. Different subsets of var genes exist that are
associated with different upstream control elements [25,26]
and functional properties [27,28]. Importantly, differences in
the functional properties of the proteins appear to be
reﬂected in the sequence of the Duffy-binding-like (DBL) a
domain, the only var domain that is PCR ampliﬁable from
nearly all var genes (See Figure 1A for more details).
A key question is whether the genetic structuring observed
in 3D7 is universal enough to allow the development of a
biologically meaningful var gene typing system. Here we have
addressed this question using large-scale sequencing of short
var sequence tags from the DBLa domain of genomic DNA
and expressed transcripts from clinical parasite isolates from
Kenya. Though diverse, the DBLa domain present in most
genes in 3D7 can be readily ampliﬁed using a set of universal
primers [29]. We demonstrate a high degree of underlying
similarity between the distributions of var sequences in Kenya
and var sequences present within the genome of a fully
sequenced parasite isolate 3D7. Second, we show how speciﬁc
sequence features can be used to classify the sequences into
groups that allow the var expression patterns of different
clinical parasite isolates to be compared directly.
Results
A total of 1,746 var DBLa clones were successfully
sequenced from 12 ﬁeld isolates using the DBLaAF9 and
DBLaBR primers (Figure 1A;. see Table S1 for patient
information). Of these, 722 clones were sequenced from
cDNA and 1,024 from genomic DNA (Table S1; see Dataset S1
for a complete list of the sequences). Overall, a total of 878
non-identical sequences were identiﬁed (see Text S1). The
sequences were too diverse for direct comparisons between
isolates, and there was virtually no overlap between sequences
of different isolates. We therefore focused on features from
these sequences that would provide more general informa-
tion about the var genes to which they belong.
DBLa Sequences Contain Semi-Conserved Features
Smith et al. [30] have previously noted from the analysis of
var sequences from laboratory isolates that the different
domains of var genes contain islands of homology that can be
used to distinguish different classes of DBLa domains, called
DBLa and DBLa1. Within the region we ampliﬁed, the
positions that were most discriminatory between DBLa and
DBLa1 domains corresponded with two cysteine residues [27].
We therefore analysed the amino acid composition of the
ampliﬁed sequences from Kiliﬁ, Kenya. For all the amino acids
apart from cysteine, the frequencies were distributed around
single modal values (data not shown). In contrast, the majority
of DBLa sequences contained either two or four cysteine
residues,withonlyaminoritycontainingone,three,ﬁve,orsix
cysteines (Figure 1B; such sequences are hereafter referred to
as cys2, cys4, and cysX types, respectively). This is entirely
consistent with the 3D7 var genes. DBLa1 sequences are cys2
while most DBLa sequences are cys4. The functional impor-
t a n c eo fc y s t e i n er e s i d u e sw i t h i nt h eD B L a domain is
supported by the observation that parasites from severe
malaria cases from Brazil tend to express var genes containing
DBLadomainswithreducednumbersofcysteineresidues[31].
Next, amino acid motifs occurring at four ﬁxed positions
within the sequenced regions were chosen. These will be
referred to hereafter as positions of limited variability 1 to 4
(PoLV1–4; Figure 1C). Each PoLV was four amino acids in
length and situated directly adjacent to conserved amino acid
residues at the fringes of the previously deﬁned islands of
homology. Thus, each PoLV was located at identical relative
positions within each DBLa sequence. The PoLV motifs and
cysteine count were used as features to classify the DBLa
sequences further.
Sequences from Kilifi and from a Laboratory Isolate
Contain Similar Distributions of Semi-Conserved Features
The distribution of DBLa features between different var
genes was examined in the full genome sequence of 3D7 [1].
In the entire 3D7 repertoire of 59 var genes there are 17
variants of PoLV1, six of PoLV2, 13 of PoLV3, and eight of
PoLV4. We compared the DBLa features in 3D7 with those
found among different Kiliﬁ sequences. The majority of Kiliﬁ
sequences contained PoLV motifs that were found in the 3D7
genome (Figure 2A; Text S2). Furthermore, there was a close
similarity between the distribution of PoLV motifs among var
genes from the 3D7 genome and among the Kiliﬁ sequences
(Figure 2A). In both sets of sequences a similar hierarchy was
evident in the frequency of variants of each sequence feature,
with the same features being common and rare in each. The
similarity between Kiliﬁ and 3D7 sequences extended to the
associations between different DBLa features. For example,
Figure 2B shows the tendency of the different PoLV motifs
to be associated with cys2 sequences. The same PoLV motifs
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Synopsis
Hope that it will be possible to develop a malaria vaccine is
supported by the fact that individuals who have grown up in malaria
endemic regions learn to carry malarial infections without suffering
disease. Surprisingly little is still known about how this immunity
develops. Much current research focuses on how the host develops
immune responses to parasite antigens that are exposed to the host
immune system. A major family of such antigens are inserted into
the surface of parasite-infected erythrocytes, where they undergo
antigenic switching to evade a developing antibody response. These
proteins are encoded by a family of approximately 60 var genes,
variants of which are present in every parasite genome.
The extreme diversity of the var genes has prevented meaningful
comparison of their expression in clinical isolates. However, the
authors of this paper show that var genes can be placed in groups
that have a similar representation in the genomes of all parasites
that the authors collected from Kenyan children. Having demon-
strated an underlying similarity at the genomic level, the authors
show that the var expression patterns vary markedly between
different patients. The expression levels of specific groups of var
genes was associated with poorly developed antibody responses in
the children and a well-established parasite virulence phenotype.
The study provides tools for exploring how host and parasite adapt
to one another as immunity develops.Figure 1. Organizational Features of var Genes
(A) var gene organization. The var genes are complex, multi-domain structures composed of variable numbers of DBL domains (rectangles) of different
sequence classes (DBLa,- b,- c,- d, and -e plus several heterogeneous DBLX) and cysteine-rich interdomain regions (CIDR, ovals), also of different classes
(CIDRa,- b, and -c). Despite this complexity, the majority of var genes in the 3D7 genome can be described according to (1) whether they belong to a
small set of long genes that encode PfEMP1 molecules with 6–9 domains or to a much larger set of short genes that encode short PfEMP1 molecules
with only four domains; (2) their telomeric or internal position within the chromosome; (3) their direction of transcription, either towards the telomere
or towards the centromere; (4) the sequence of their second most N-terminal DBL domain (DBL2), either DBL2b, DBL2d, or DBL2c; and (5) their
association with one of five upstream (ups) regulatory sequences, upsA, upsB, upsC, upsD, or upsE [1,25,26]. The genes do not fall randomly within
these categories. For example, of the long var genes, most have a DBL2b and are associated with upsA, whereas most short genes have a DBL2d. Of the
telomeric genes, most of those that are transcribed towards the telomere are associated with upsA, whereas all those transcribed towards the
centromere are associated with upsB [28,33]. This apparent genetic structuring is associated with functional specialization. A subset of CIDR regions
(CIDRa) situated immediately 39 of DBLa bind to CD36 when expressed as recombinant peptides (teal shaded oval). These regions are generally
replaced by non-CD36-binding CIDR regions in long var genes [27]. In 3D7, long var genes tend to be associated with a distinct subset of DBLa domains
called ‘‘DBLa1’’ [27]. This observation is potentially very useful since DBLa and DBLa1 sequences can be PCR amplified from nearly all var genes using a
universal set of degenerate primers [29]. Examples of long and short var genes found in the 3D7 genome are shown. A white square is used to represent
the conserved exon 2 at the C-terminal end. Short genes are relatively conserved in domain structure. Long genes have variable organization. Two
forms of PCR product were cloned and sequenced. DBLa-specific primers (DBLaAF9 and DBLaBR) were used to amplify DBLa sequences from cDNA and
genomic DNA from each parasite isolate. DBLaAF9 and BetaR primers were used to amplify genomic DNA from isolates 4111 and 4161. Four further
primers were used in different combinations to amplify between DBLa and ups.
(B) Distinct DBLa sequences categorized according to the number of cysteine residues in the sequence. The number of cysteines present in each
distinct DBLa sequence is plotted against the length of the sequence.
(C) The location of sequence features. PoLVs are in gray. The conserved amino acids to which they are anchored are in blue. Cysteine residues are
highlighted in green. The derived ‘‘sequence signature’’ for each clone is indicated.
DOI: 10.1371/journal.ppat.0010026.g001
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and Kiliﬁ sequences, and the overall pattern of positive and
negative associations was strikingly similar (Mantel-Haenszel
test, p ¼ 0.000002).
To test whether similarity between Kiliﬁ and 3D7 sequen-
ces extended as far as the next downstream DBL region (see
Figure 1A), genomic DNA from two ﬁeld isolates, 4111 and
4161, was ampliﬁed with primers DBLaAF9 and BetaR located
within the DBLa and DBL2b regions, respectively. Cloned
PCR products were sequenced at both ends to determine the
DBLa sequence at the 39 end and conﬁrm correct priming
within DBL2b at the 59 end. Figure 2C shows the distribution
of DBLa features among distinct sequences. Among these
clones there was a clear bias towards sequence features that
are associated with DBL2b in the 3D7 genome, namely
PoLV1LFLG, PoLV2LREA, PoLV4PTNL, and cys2. A similar
conservation was evident upstream (see Text S3). Taken
together, these observations suggest that despite being
extremely diverse, DBLa sequences are built around a ﬁnite
collection of building blocks whose relationships with one
another follow underlying ground rules.
Assignment of DBLa Sequences to Groups
To simplify comparisons between the different isolates and
to summarize the proﬁle of expression, we sought an
algorithm to assign the sequences to groups. Though in 3D7
cys2-type DBLa sequences correspond very well with those
that were previously classiﬁed as DBLa1 [27], we did not
expect to identify additional discrete subgroups of sequence
because of the high frequency of recombination between var
genes [20,21,32]. However, inspection of the sequences
suggested an approach to identifying subgroups. As shown
in Figure 1B, cys2 DBLa sequences were signiﬁcantly shorter
than cys4 DBLa sequences ( Mann-Whitney U test, p ,
0.0001). This is consistent with these forming distinct
sequence groups. We considered the possibility that addi-
tional sequence features may exist that are independently
associated with DBLa sequence length. Using logistic regres-
sion analysis, two such groups of sequence features were
identiﬁed (see Materials and Methods and Text S4). These
were PoLV1MFK* and PoLV2*REY (with the asterisk marking
degenerate positions). PoLV2*REY was associated with short
sequences in both cys2 and cys4 sequences. PoLV1MFK* was
found exclusively in cys2 sequences and was independently
associated with short sequences (Figure 3A). Among the cys2
sequences there was a complete absence of sequences that
contained both PoLV1MFK* and PoLV2*REY.T h i si sa
signiﬁcant departure from a random distribution (Fisher’s
exact test, p , 0.001), suggesting that these features deﬁne
subgroups of cys2 sequence.
We used this information to assign each sequence to one of
six groups (Figure 3A). Since discrimination by number of
cysteine residues corresponded well with the previous
classiﬁcation of DBLa regions from 3D7 [27], sequences were
ﬁrst divided into cys2, cys4, and cysX sequences. Cys2
sequences were then divided into those containing
PoLV1MFK* (group 1), those containing PoLV2*REY (group
2), and those containing neither (group 3). Cys4 sequences
were divided into those without PoLV2*REY (group 4) and
those with PoLV2*REY (group 5). CysX sequences were placed
Figure 2. Conservation of Sequence Features between 3D7 and Kilifi Field Isolates
(A) Distribution of sequence features within the 3D7 genome (black bars) and in Kilifi sequences (green bars). Sequence features not shared between
Kenyan isolates and 3D7 are marked ‘‘other’’.
(B) Relationships between sequence features in sequences from Kilifi and 3D7: distribution of sequence features among cys2 sequences relative to
those with non-cys2 sequences. The Cramer’s V statistic (y-axis) indicates whether each of the listed sequence features was positively (V . 0) or
negatively (V , 0) associated with cys2 sequences. Sequences from Kilifi are indicated with green bars; those from 3D7 are indicated by black bars.
(C) The distribution of DBLa sequence features within var genes containing a DBL2b domain. PCR was performed on genomic DNA from two field
isolates, 4161 and 4111 (see Figure 1A for amplification details). The percentage of distinct sequences containing each of the features listed is shown for
Kilifi sequences (green bars) and is compared to the distribution of similar sequences from the 3D7 genome sequence (black bars).
DOI: 10.1371/journal.ppat.0010026.g002
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two features, groups 3 and 4 were deﬁned with one feature,
and group 6 contained the remaining unusual sequences.
We tested this system of classiﬁcation on full-length var
gene sequences from the 3D7. The full-length var genes have
previously been classiﬁed into ﬁve major groups (A to E)
using both coding and upstream non-coding regions [1,28,33].
Figure 3B shows how DBLa sequences from 3D7, classiﬁed
using our algorithm, are distributed between the ﬁve var gene
groups. Figure 3C shows how the DBLa sequences are
distributed between short and long var genes. There were
striking differences in the distribution of DBLa sequences
particularly comparing group A, B, and C var genes and long
and short var genes (see Text S3).
To determine the relationships between the six var groups,
30 randomly chosen sequences from each group were globally
aligned using ClustalW analysis. A pairwise identity matrix
was then constructed with the sequences sorted into their six
groups (Figure 4A). It is clear from this comparison that,
despite being deﬁned using only a small amount of sequence
information, groups 1, 2, and 5 form discrete sequence
groups, since more sequence identity is shared between
members of the same group than between groups. The
distinction between groups 1 and 5 is particularly striking.
Though groups 3 and 4 do not appear to form such discrete
groups, the distinction between groups 2 and 4 was marked.
Group 6 does not deﬁne a discrete sequence subset when
analysed globally in this way, and may contain sequences
derived from a variety of different recombination events.
Overall, this identity matrix suggested a complex web of
relationships between the different sequence groups. Visual
inspection of the sequences suggested that the similarity
between groups 2 and 5 extended 59 from PoLV2*REY. There-
fore, to explore the relationships between these groups, we
generated two further identity matrices, the ﬁrst comparing
the region from the 59 end of PoLV3 to the 39 end of PoLV4
(Figure 4B) and the second comparing the region from the 59
end of PoLV1 to the 39 end of PoLV2 (Figure 4C). These two
comparisons gave strikingly different pictures of the inter-
relatedness of thesegroups. From Figure 3B itis clearthat cys2
sequences (groups 1–3) are distinct from cys4 sequences
(groups4and5).However,Figure3Cshowsthatthisdistinction
breaks down in the regions between PoLV1 and PoLV2. Thus,
groups 2 and 5 and groups 3 and 4 share some identity within
this region. From this analysis it is unclear whether these two
related pairs of groups originated from ancestral hybrid
sequences or whether recombination between cys2 and cys4
still occurs. What is clear is that group1 is distinct from cys4
sequences over the entire length of the sampled region.
Sequence Groups Are Consistently Represented in
Genomic DNA from Clinical Isolates but Are Differentially
Expressed
Using the above system of classiﬁcation each of 12 clinical
parasite isolates were compared (Figure 5). Figure 5A and 5C
divide all 1,746 DBLa sequences by (1) whether they were
cloned from genomic DNA (Figure 5A) or cDNA (Figure 5C),
(2) the parasite isolate from which they were isolated, and (3)
the group to which they were assigned. The cloning
frequencies of genomic sequences from each group were
fairly constant between parasite isolates and close to those
expected from the distribution of var genes in the 3D7
genome (Figure 5A). This suggests that the number of
sequences from each group was relatively constant between
different parasite genomes. In contrast, there was consid-
erable variation in the cloning frequency of cDNA-derived
sequences (Figures 5C and S1). To highlight this, parasite
isolates were sorted left to right according to increasing
cloning frequency of cys2 cDNA sequences. Between the 12
isolates there was a signiﬁcant correlation between the
expression of group 1 and group 2 (rs ¼ 0.67, p ¼ 0.02),
suggesting that they may be under similar expression control.
Based on their distribution within the 3D7 genome (see
Figure 3C), we expected cys2 sequences to be associated with
long var genes [1]. To conﬁrm this, Northern blots of total
RNA from each parasite isolate were hybridized to a generic
var-speciﬁc probe from the relatively conserved 59 exon 2
region. There was a good correspondence between the size of
the bands (Figure 5E) and the dominant cDNA sequences
from each isolate (Figure 5D). In ﬁve of seven samples that
had a dominant band less than or equal to 9 kb in length, the
dominant sequence was cys4 type. In ﬁve of ﬁve samples that
had a dominant band greater than 9 kb, the dominant
sequence was cys2 type (Fisher exact test, two-tailed, p¼0.03).
The Parasite Rosetting Phenotype Is Associated with
Expression of Group 2 Sequence
As a test of the validity of our DBLa sampling and grouping
strategy, we tested whether the parasite rosetting phenotype is
associated with expression of speciﬁc DBLa sequence groups.
Since this phenotype is mediated by the DBLa domain of
Figure 3. Sequence Groups
(A) DBLa sequences were divided into six sequence groups: sequence
groups 1–3 are those that contain two cysteine residues (cys2), and
sequence groups 4 and 5 are sequences that contain four cysteine
residues (cys4). Sequence group 6 includes sequences with one, three,
five, or six cysteines (cysX). Sequence groups 2 and 5 contain PoLV2*REY.
Sequence group 1 contains PoLV1MFK*. The length of each distinct DBLa
sequence within each sequence group is indicated.
(B and C) The distribution of 3D7 var genes in each DBLa sequence
group among groups previously defined on the basis of coding and
upstream non-coding regions of full-length var sequences [1,33] (B) and
the overall length of the genes (C). Genes are classified as short if they
have 4–5 domains and long if they have 6–9 domains (see Text S6).
DOI: 10.1371/journal.ppat.0010026.g003
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associated with rosetting may be associated with the sequence
featuresusedtodeﬁneourgroups.Insupportofthis,astriking
positive association was observed between group 2 expression
and the percentage of infected erythrocytes that formed
rosettes (rs ¼ 0.92, p , 0.001, corrected for six comparisons
(Bonferroni); Figures 6, S2C, and S2D). Furthermore, the two
parasite isolates with the highest rosetting rates expressed
dominant group 2 sequences with the same combination of
sequencefeatures.(i.e.,thesequence‘‘signature’’;seeMaterials
and Methods, Text S5, and Figure S3 for more details; this
particular sequence signature was called ‘‘sig2’’ in Figure S3).
These highly similar sequences are shown in Figure 6D.
var Gene Expression in the Infecting Parasite Population
Reflects the Host VSA Antibody Response at the Time of
Disease
Previous studies predicted that as children build up a
repertoire of anti-VSA antibodies, the proportion of VSAs
that can be expressed by the infecting parasite population is
diminished [16]. More recently, mathematical modelling has
suggested that sequential expression of single VSAs can be
sustained by the anti-VSA antibodies [34]. Between parasite
isolates in this study, there was considerable variation in the
extenttowhichthecDNAsequencesweredominatedbyasmall
number of sequences. Figure 5D shows the extent to which the
mostdominantsequencesfromeachparasiteisolateaccounted
for the entire collection of clones from that isolate among
cDNA sequences (i.e., the homogeneity of the collection of
sequences; see Materials and Methods). From Figure 5D it is
clear that among the cDNA clones, dominant sequences were
identiﬁed fromeach of groups 1–5 with no strikingassociation
between any particular group and the disease severity of the
infected child (see also Figures 6C, S1, S2A, and S2B).
If the expressed var genes correspond with VSAs expressed
on the infected erythrocyte, then, following from previous
studies, we would expect to observe a positive association
between the homogeneity of the var message and the
repertoire of VSA antibodies carried by each child at the
time of disease (see Figure 5F). In support of this, there was
evidence for such an association among the cDNA sequences
(rs ¼ 0.81, p ¼ 0.002; Figure 5D) but not among the gDNA
sequences (rs ¼  0.37, p ¼ 0.23; Figure 5B). Previous
serological studies have further led to the suggestion that a
Figure 4. Global Comparisons of Sequences Falling in Six Sequence Groups
Using ClustalW, pair-wise sequence identity comparisons were made between 30 randomly selected, distinct sequences from each sequence group.
Pair-wise comparisons are expressed in an identity matrix, in which the percent identity between pairs of sequence is represented in different shadeso f
gray.
(A) Full-length sequence comparisons.
(B) Sequence comparisons of the region from the 59 end of PoLV3 to the 39 end of PoLV4.
(C) Sequence comparisons of the region from the 59 end of PoLV1 to the 39 end of PoLV2.
DOI: 10.1371/journal.ppat.0010026.g004
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immune selection [17,18]. To test whether any of the DBLa
groups show evidence of being under high immune selection
relative to the other groups, we tested for a negative
association between the relative expression of each of the
groups and the VSA antibody repertoire of the infected child.
Evidence for such an association was found for sequence
group 1 (rs ¼  0.68, p ¼ 0.015, p ¼ 0.088 after Bonferroni
correction for six comparisons; see Figures 6B, S2E, and S2F).
Though this association clearly needs to be conﬁrmed in
larger studies, the fact that group1 sequences were relatively
well conserved between isolates agrees with predictions from
the previous serological data.
Discussion
Despite years of research very little is known about how the
host–parasite relationship changes as naturally acquired anti-
malarial immunity develops. More speciﬁcally, we lack
molecular tools for measuring changes in the parasite as it
adapts to the development of clinical immunity in vivo. Such
tools could provide a powerful means of dissecting the
protective components of host response, a ﬁrst step in the
identiﬁcation of new vaccine candidates. A main requirement
for such tools is that they can be used in ﬁeld-based studies.
Here we have assessed a simple approach using large-scale
sequencing of short stretches of sequence from DBLa,a
region that, though highly diverse, is present in the majority
of var genes.
Expectations that such an approach could generate data
that would reﬂect the host–parasite relationship at the time
of disease have until recently been low. This has been due to
uncertainty about whether the high recombination rate
between var genes and their extreme diversity would allow
meaningful comparisons between isolates [20,21,32]. The 3D7
Figure 5. var Gene Expression Profiling
(A–D) Each DBLa sequence was assigned to one of six sequence groups (Figure 3). The proportion of clones that fell into each of the six groups was
calculated separately for genomic clones (A) and cDNA clones (C). (A) includes the distribution of sequences from the 3D7 genome (right). (B) and (D)
show for each isolate the percent of genomic DNA (B) or cDNA clones (D) corresponding to the three most dominantly cloned genomic or cDNA
sequences from that isolate. Isolates are ordered left to right according to the overall proportion of cys2 clones isolated from cDNA. Underlined ID
numbers correspond to children with severe malaria.
(E) Northern blots of total RNA from each of the parasite isolates. Blots were hybridized to a generic var exon 2 probe, varc, corresponding to a
conserved region within all var genes. The position of var genes expressed by the laboratory parasite line Palo Alto is indicated by lines to the left of
each lane. These are approximately 9 kb and 11 kb in length.
(F) The VSA antibody repertoire carried at the time of acute disease by each patient. The y-axis shows the number of a panel of six parasite isolates that
were recognised by the acute plasma from each child.
DOI: 10.1371/journal.ppat.0010026.g005
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P. falciparum var Expression during Malariagenome sequence [1] has provided more encouraging
information. The location of var genes in both internal and
telomeric locations and their mixed direction of transcrip-
tion set up the conditions for genetic structuring. This is
supported by the existence within the 3D7 genome of two
groups of var genes encoding PfEMP1 with different func-
tional properties [27]. The two groups of genes carry different
DBLa sequences deﬁned as DBLa and DBLa1 [27]. These
observations opened up the possibility of obtaining func-
tionally relevant data from ﬁeld isolates using only limited
sequence data. However, it was uncertain how useful these
deﬁnitions would be to ﬁeld studies.
Here we analysed a large number of different sequences
from the DBLa region of var genes from Kiliﬁ, Kenya,
focusing on a limited number of semi-conserved sequence
features. The data strongly support the existence of an
underlying order that extends from the single genome to the
parasite population as a whole. This enabled us to use the 3D7
genome as a basic reference for interpretation of the ﬁeld
data. Overall, the similarity between Kiliﬁ and 3D7 sequences
was extensive, in terms of (1) the range of sequence features
observed and their similar frequency distribution, (2) their
relationships with each other within the sequence, and (3)
their relationship to features outside the sequence region
that was sampled. Most notably, within the region we have
sequenced the main deﬁning feature of DBLa1 sequences in
3D7 is the existence of two cysteine residues (cys2) rather
than the normal four cysteines (cys4). In the ﬁeld isolates,
apart from a small minority, the sequences could be classiﬁed
as either cys2 or cys4. These observations together help
clarify an interesting earlier observation from Brazil, where
DBLa sequences containing reduced numbers of cysteines
(corresponding to our cys2 sequences) tended to be expressed
in children with severe malaria [31].
Comparison of the lengths of the DBLa sequences revealed
that cys2 types were signiﬁcantly shorter than cys4 types.
Other sequence features independently associated with
sequence length were subsequently identiﬁed and used to
Figure 6. Relationships between the Expression of Each DBLa Sequence Group and Markers of the Host–Parasite Relationship
In each graph the Spearman’s rank correlation coefficient (rs) is shown for each sequence group. Significance without Bonferroni correction is indicated
as follows: *, p , 0.05; **, p , 0.001.
(A) Correlation between expression of each sequence group and parasite rosetting (percent of infected erythrocytes forming rosettes).
(B) Correlation between expression of each sequence group and host VSA antibody repertoire (the number of a panel of six isolates recognised by the
patient plasma).
(C) Correlation between expression of each sequence group and severe malaria.
(D) Alignments of sequences associated with parasite rosetting. Similar sequences were found to be dominant in two isolates (4140 and 4187) with the
highest rosetting frequency. In isolate 4187, the two most dominant sequences (4187_dom1 and 4187_dom2) were highly similar. All three sequences
shown have the same sequence signature, ‘‘sig2’’: LYLD-VERY-KAIT-2-PTNL.
DOI: 10.1371/journal.ppat.0010026.g006
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classifying the sequences. The practical usefulness of these
groupings is supported by the striking association between
sequence group 2 expression and parasite rosetting. The
rosetting phenotype is a well established virulence phenotype
mediated by binding of a subset of DBLa domains to
complement receptor 1 (CR1) on erythrocytes and has been
found in several previous studies to be associated with severe
malaria [35,36]. Surprisingly, these sequences were not
related to previously identiﬁed rosetting var genes such as
R29 [12] or FCR3S1.2var1 [13], which fall in groups 1 and 4,
respectively, suggesting that they may represent a novel class
of rosetting var genes.
In most of the isolates there were clear dominant cDNA
sequences, and the dominance of particular sequences in
different infections was consistent with previous studies of
var gene expression from ﬁeld isolates [37,38]. This challenges
previous ideas based on studies of var gene expression in
laboratory isolates. Previous studies suggested that all var
genes may be switched on in the immature ring stages, but
only one is expressed in mature stages. These data suggested a
post-transcriptional level of control that would prevent
meaningful data being obtained from uncultured parasite
isolates [39–41]. Though Kaestli et al. [38] took the precaution
to pre-select for full-length transcripts to remove the
possibility of amplifying incomplete transcripts, neither
Peters et al. [37] nor ourselves performed this step, suggesting
that background transcription may not be a cause for
concern in the interpretation of ﬁeld studies.
The primary aim of sampling var gene sequences from
clinical isolates was to use the information to track changes in
var gene expression associated with the development of
naturally acquired immunity to malaria. It is important for
such studies to be carried out over a long period of time and
in different geographical locations. However, as a ﬁrst step, it
was encouraging to ﬁnd that the repertoire of VSA antibodies
carried by a child at the time of disease correlated with both
the tendency of the cDNA sequences to be dominated by a
small number of sequences, and their bias away from a small
group of relatively conserved cys2 sequences (group 1). Both
these observations ﬁt in well with previous serological and
theoretical studies that suggest that theVSA antibody
response both supports sequential expression of single VSAs
[34] and selects against those that are most conserved.
Previous serological studies have led to the suggestion that
a restricted subset of commonly recognised PfEMP1 mole-
cules are associated with both low host immunity and severe
malaria [17,18,23]. In an attempt to select for the expression
of such molecules in vitro, Jensen et al. [42] selected the 3D7
parasite line on IgG from malaria-exposed children. Several
var genes appeared to be speciﬁcally selected by these
naturally acquired antibodies. The DBLa tag regions of the
majority of these were found to be cys2 sequences, though not
speciﬁcally from group 1. A key question for future research
is why certain var genes would be maintained in the genome if
they are particularly sensitive to immune selection. If such
genes have speciﬁc functional properties, it would be
important to examine these in detail to assess their potential
usefulness as vaccine candidates.
However, in the present study there was no clear evidence
for any particular sequence group being associated with
severe malaria. As noted above, Kirchgatter et al. [31]
previously observed that children with severe malaria tend
toexpress DBLa sequences with cys2 sequences, and Bian et al.
[43] have observed that parasites causing severe malaria tend
to express long PfEMP1 molecules [43]. In the 3D7 genome
both these are characteristics shared by var genes that lie
downstream of upsA control elements (see Figure 1A). These
observations together with those of Jensen et al. [42] may
suggest a speciﬁc role for upsA var genes in severe malaria. In
the present study, the clear bias in parasites from two severe
cases away from expression of cys2 DBLa sequences suggests
that some caution is needed in regard to this interpretation.
However, the strong association of a subgroup of cys2
sequences (group 2) with rosetting and the observation that
parasites from two of the six severe cases expressed very
similar group 2 dominant sequences are consistent with the
idea that some children with severe malaria express a
restricted subset of cys2 var genes. More samples are clearly
needed to conﬁrm this observation.
In future studies with larger numbers of parasite isolates it
will be interesting to explore DBLa expression patterns in
relation to other aspects of the host–parasite interaction,
such as the number of parasite genotypes present, host
endothelial cell binding phenotype, and various components
of the host immune response. Though initially it would be
important to carry out these studies using DNA sequence
data, the fact that sequence groups can be deﬁned using short
sequence motifs suggests that approaches based on micro-
array and real-time PCR analysis could be developed to
distinguish between the expression of different groups of var
sequences. In addition, the close relationship between PCR
product length and the sequence group of the products raises
the possibility that inexpensive approaches to var expression
typing might be developed using PCR product length data.
In conclusion, we have shown that var genes from both ﬁeld
and laboratory isolates can be classiﬁed into biologically
meaningful subsets based on small blocks of semi-conserved
sequence. Further sequencing of var genes from a much
larger number of parasites derived from patients that have
been rigorously categorised with respect to clinical presenta-
tion and parasite phenotype is clearly necessary. By focusing
attention on subgroups of var genes that are associated with
parasite virulence and host immune status, such studies may
provide further information with implications for malaria
intervention.
Materials and Methods
Study site. The study was carried out at Kiliﬁ District Hospital,
situated 50 km north of Mombasa on the coast of Kenya. The hospital
has a high-dependency ward to treat children with severe life-
threatening malaria, a paediatric ward to treat children with
moderate malaria, and an outpatient department to treat children
with mild malaria.
Sample collection. Children were recruited if they had a primary
diagnosis of malaria and parasitaemia   one trophozoite per 100
uninfected erythrocytes [17]. Isolates were collected and white blood
cells removed as described previously [22]. For each isolate a sample
of acute plasma was stored at  20 8C. Parasites were collected from
children attending hospital between July 1998 and February 1999 and
have been described previously [17,44]. Twelve patients were selected
for the study: six with mild disease and six with severe disease.
Serotyping of plasma. Plasma from each of the 12 patients was
tested by agglutination assay against six parasite isolates from blood
group O individuals (ID numbers 4513, 4518, 1759, 4542, 4508, and
4528) who came to hospital with malaria either between January and
August 2000, or, in the case of 1759, in December 1995 [44]. The VSA
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the number of the six target isolates that were agglutinated.
Agglutination assays. Parasites were cultured until they were
middle to late pigmented trophozoites, as described previously [22].
Assays were performed in microtitre plates (Falcon, Becton-Dick-
inson,Palo Alto,California, United States)at 4% haematocrit in RPMI
at a parasitaemia of 1–2 trophozoites per 100 uninfected erythrocytes
in a 12.5-ll total assay volume in the presence of 2.5 ll of plasma. Cells
were rotated for 1 h as described previously [22]. Assays were scored
using the dry agglutinate method as described previously [17].
Rosetting assay. Cells (0.5 ll) were resuspended in 9.5 ll of RPMI
containing 5 lg/ml acridine orange. Following the addition of 2.5 ll
of non-immune European serum, cells were rotated for 30 min on a
vertical rotator and the entire reaction volume pipetted onto a glass
slide, covered with a coverslip, and observed under a ﬂuorescence
microscope (Nikon, Tokyo, Japan). Rosetting was scored as the
percentage of 100 mature trophozoites that adhered to at least two
uninfected erythrocytes.
Characterization of DBLa sequences. Pellets (100 lm) of packed
infected erythrocytes were collected and, following lymphocyte and
phagocyte depletion, were stored in Trizol (Invitrogen, Paisley,
United Kingdom) at  30 8C. RNA was prepared as described
previously [45]. To amplify var from RNA, the RNA was ﬁrst treated
with DNAse I (DNAse Free, Ambion, Cambridge, United Kingdom)
according to the manufacturer’s instructions. The DNAse was
removed using Ambion DNase inactivation reagent. RNA (2 ll) was
reverse transcribed using reverse transcriptase (Invitrogen Super-
scriptII). For each isolate a negative control reaction was performed
in the absence of reverse transcriptase to ensure that all contaminat-
ing DNA had been removed by DNAseI pre-treatment. Sufﬁcient
DNA was present in the untreated RNA sample for PCR ampliﬁcation
of genomic DNA. Suspended sample (1 ll) was diluted in 10 llo f
water, and 1 ll was ampliﬁed directly by PCR. DBLa sequences were
ampliﬁed with the following primers: DBLaAF9, GCACG(A/
C)AGTTT(C*/T)GC, and DBLaBR, GCCCATTC(G/C)TCGAACCA,
modiﬁed from [29] (Figure 1A). The nucleotide marked with an
asterisk indicates a modiﬁcation from the originally described primer
DBLaAF. This change was introduced to broaden the range of
sequences that can be ampliﬁed. PCR ampliﬁcations between DBL1a
and DBL2b were performed using the following primers: DBLaAF9,
see above, and BetaR, GA/CCCAC/TTCIGC/TCATCCA. The following
conditions were used. For isolation of DBLa sequences, 35 cycles of
PCR were performed in 25 ll using an annealing temperature of 42
8C and a 30-s extension time at 65 8C in the presence of 0.2 U of
Amplitaq polymerase (Applied Biosystems, Foster City, California,
United States) and 3 mM MgCl2 to give a product of 400 bp.
Ampliﬁcation between DBLa and DBL2b was performed in the
presence of BioXact polymerase (Bioline, London, United Kingdom)
in the presence of 3 mM MgCl2 with an annealing temperature of 50
8C and extension time of 2 min at 65 8C to give a product length of
approximately 2.3 kb. Following PCR, DBLa sequences were puriﬁed
using Sephacryl (Amersham Biosciences, Amersham, United King-
dom). Products obtained by ampliﬁcation between DBLaAF9 and
BetaR were size selected on an ethidium-bromide-stained agarose gel
and puriﬁed using a Qiagen (Valencia, California, United States) gel
extraction kit. DNA was ligated into either TA vector or TOPO vector
(Invitrogen) and used to transform TOP10 cells. From each clinical
isolate we aimed to sequence approximately 100 genomic DNA and
50 cDNA DBLa clones. Sequencing was carried out using M13 reverse
a n dT 7p r i m e r s( 3p m o l )w i t hB i g D y eT e r m i n a t o rv 3 . 1c y c l e
sequencing kit (Applied Biosystems). Samples were run on Applied
Biosystems 3700 or 3730 sequencing machines.
Ampliﬁcation of DNA upstream of DBLa. The following primers
were used to test the relationship between (1) DBLa sequence
features PoLV1MFKR (amino acid sequence motif MFKR at PoLV1;
see Figure 1C) or PoLV4PTYF and (2) upstream sequences upsA or
upsB (see Figure 1A). Reverse primers MK3, TCAT
TACGTTTAAACATATC (speciﬁc to PoLV1MFKR), and PTYF39,
ACGTAGTCAAAATATGTGG (speciﬁc to PoLV3PTYF); forward
primers upsA750, AACATKGTTCTATTTTCTC, and upsB,
TTGCCTCTDTTGTTATCTC, speciﬁc to upsA and upsB, respec-
tively. All reactions were performed in the presence of 3 mM MgCl2
using an annealing temperature of 47 8C, 35 cycles, and an
extension time of 1 min at 65 8C with Amplitaq polymerase in
the presence of Taqstart reagent (Clontech, Becton-Dickinson). See
also Text S3.
Selection of sequences for analysis. DNA subclones were selected
for analysis if at least one of the pair of sequence reads contained a
single open reading frame and began and ended within previously
identiﬁed ‘‘homology blocks’’ of DBLa [30]. From the pair of
sequence reads from each clone the best quality single read was
chosen for analysis. Sequences selected for analysis were all open
reading frames beginning at the position of the 59 consensus motif
DIGDI within homology block D and ending at the position of the 39
consensus motif PQYLR within homology block H. Five different
sequences (eight clones in total) were excluded from the analysis
because they were from non-alpha DBL domains.
Extraction of sequence features. Translated sequences were
aligned in batches using ClustalW analysis (http://www.ebi.ac.uk/
clustalw/) using the default settings (Gonnet250 matrix, gap opening
penalty¼ 10.0, gap extension penalty ¼ 0.2, gap closing penalty ¼  1,
gap separation penalty ¼ 4). Sequence features listed in Figure 1C
were extracted from the sequence using GeneDoc software (http://
www.psc.edu/biomed/genedoc/) and exported into Microsoft (Seattle,
Washington, United States) Excel and Stata version 6.0 (StataCorp,
College Station, Texas, United States) for further analysis.
Sequence analysis. To test the association between sequence
features within DBLa sequences, the Cramer’s V statistic was used
in Stata. This is a representation of v
2, but is bounded between  1
and þ1. To identify sequence features that were independently
associated with DBLa sequence length, the following strategy was
used. (1) The association between each PoLV motif and sequence
length was determined using the Mann Whitney U test. (2) PoLV
motifs with a highly signiﬁcant negative association with sequence
length (p , 0.0001) were identiﬁed. (3) These sequence features were
grouped allowing one degenerate position. (4) Logistic regression was
used to screen each DBLa sequence feature or group of features
simultaneously for those that were independently associated with
sequence length. See Text S4 for more details.
Sequence signatures. Because of the high overall sequence
diversity, very few of the sequences had absolute matches between
isolates. To make more general comparisons between different
sequences and to identify common and rare sequence types within
each group, DBLa sequence features were used to reduce each
sequence to a ‘‘signature’’ of standard length. The signature consisted
of the string of amino acids at each of the PoLVs together with the
cysteine count (see Figure 1C for examples). Sequence signatures are
discussed further in Text S5 and Figure S3.
Deﬁnition of ‘‘distinct’’ sequences. Severaloftheanalysesdescribed
here, in particular the identiﬁcation of sequence groups, were
performed on collections of ‘‘distinct’’ sequences. A robust deﬁnition
of ‘‘distinctness’’ was required to help minimise repeated sampling of
very similar sequences arising from PCR and sequencing errors. For
this deﬁnition, two sequences were considered distinct if they had
either (1) non-identical signatures or (2) different amino acid length.
Homogeneity of cDNA expression. Homogeneity of cDNA ex-
pression was deﬁned for each isolate as the total number of cDNA
clones containing the dominant two sequences from that isolate,
expressed as a percentage of all cDNA clones sequenced from that
isolate.
Northern blot analysis. For comparison of full-length ring-stage var
RNA transcripts, Northern blots were prepared and hybridized with a
generic var exon 2 (see Figure 1A) probe as previously described [45].
A sample of laboratory isolate Palo Alto RNA was included, to allow
size comparison between samples run on different gels. The largest
commercially available markers go up to 9.5 kb, whereas the Palo Alto
sample has major var transcripts at approximately 9 kb and 11 kb.
Exposures to autoradiography ﬁlm ranged from 1 to 4 d.
Generation of sequence identity matrices. Distinct sequences from
each required category were picked at random using the RAND
function in Microsoft Excel and subjected to ClustalW analysis as
described above. Identity matrices were generated in the form of
statistics reports using GeneDoc software and the report ﬁle saved
with an *.xls extension. Files were opened in Microsoft Excel and
conditional formatting was used to shade the matrix as follows: 80%
gray (55%–100% identity), 50% gray (45%–54% identity), 25% gray
(35%–44% identity), and white (, 35% identity).
Supporting Information
Dataset S1. The 1,746 Translated DNA Sequences Used in the Study
Found at DOI: 10.1371/journal.ppat.0010026.sd001 (248 KB TXT).
Figure S1. var Expression Proﬁling
Pie charts are used to show the number of distinct sequences of each
group cloned from each parasite isolate. The size of each slice is
proportional to the number of clones of that sequence identiﬁed.
Found at DOI: 10.1371/journal.ppat.0010026.sg001 (19 KB PDF).
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P. falciparum var Expression during MalariaFigure S2. Global Analysis of Expressed DBLa Sequences between
Subsets of Parasites
To obtain a global picture of the expression of different groups of
parasites and to test the usefulness of our sequence groupings we
randomly selected 26 cDNA clones from each parasite isolate and
constructed identity matrices of pair-wise comparisons of the
sequences. Multiple sequence comparisons of all 312 sequences were
ﬁrst performed using ClustalW. The twelve isolates were then split
into various groups of six, and pairs of identity matrices were
constructed from the selected sequences as described in Materials
and Methods: mild and severe cases (A and B), low and high rosetting
(C and D), and VSA antibody positive and negative (E and F). The
expression patterns further illustrate the associations described in
the text and reveal subtle characteristics of expression patterns that
need to be explored in future studies with larger samples of parasites.
The most notable is the apparent emergence of large clusters of
similar sequences in both rosetting parasites and those from
antibody-negative children. The fact that this is not apparent in
children with severe malaria may reﬂect heterogeneity in the var
genes compatible with causing severe malaria. However, this can be
tested only by comparisons using matrices generated from much
larger pools of sequences.
Found at DOI: 10.1371/journal.ppat.0010026.sg002 (22 KB PDF).
Figure S3. Signiﬁcant Sequence Signatures from Kiliﬁ and Elsewhere
Forty-seven Kiliﬁ sequence signatures are shown of the total 393
isolated, in addition to two signatures from previously identiﬁed var
genes associated with rosetting that were not found among Kiliﬁ
sequences. Kiliﬁ sequences were considered signiﬁcant based on four
criteria: (1) being among the dominant cDNA sequences represented
in the cDNA from each isolate (dark green boxes); (2) being sequence
signatures that were isolated from more than ﬁve isolates (including
3D7); (3) being sequence signatures of full-length sequences that were
identical in two or more isolates (highlighted with a white X); or (4)
being sequence signatures shared with previously identiﬁed var genes
of note. Only sequences cloned from cDNA and representing greater
than 20% of all the cDNA clones from that isolate are shown as dark
green squares. Expressed signatures that were not the most dominant
sequence or were present in less than 20% of the sequences from
each isolate are represented as light green boxes. For dominant and
second most dominant sequence signatures from each isolate, the
percentage of cDNA sequences containing that signature is
indicated. Signatures only identiﬁed in genomic DNA from a given
isolate are indicated as light gray boxes. The sequence signatures are
divided into sequence groups 1–6 and sorted, with the sequence
signatures that were most frequently shared between isolates at the
top of each group. Within the sequence signatures listed on the left,
individual sequence features that were not found in the 3D7 genome
are highlighted with brackets. Sequence features that were the most
frequently represented within all the clones are highlighted in bold.
Those that were most frequently represented within cys2 sequences
are written in blue. The PoLV1MFK* features are highlighted in dark
red, PoLV2*REY features are highlighted in light red. Previously
described var genes that contain the sequence features listed here are
indicated on the right: AFBR41 in the 3D7 genome was found to be
dominantly expressed in a vaccinated volunteer [37]. 3D7chr5var and
FCR3varCSA are collectively known as var1. var1-like genes isolated
so far tend to have either 3D7chr5var-like or FCR3varCSA-like
sequence signatures [46–49]. The tendency of the dd2var1 gene to be
conserved between isolates has been noted previously (S. Kyes,
unpublished data). R29, FCR3S1.2-var1, and A4-AFBR19 are asso-
ciated with parasite rosetting [12,13,50]. For more on sig1 and sig2,
see Text S5.
Found at DOI: 10.1371/journal.ppat.0010026.sg003 (14 KB PDF).
Table S1. Parasite Isolates and Patients Used in This Study
Found at DOI: 10.1371/journal.ppat.0010026.st001 (57 KB DOC).
Table S2. Mann Whitney U Test Analysis of Associations between
Sequence Features and DBLa Sequence Length
Found at DOI: 10.1371/journal.ppat.0010026.st002 (66 KB DOC).
Table S3. Logistic Regression Analysis of Associations between
Sequence Features and DBLa Tag Sequence Length
Found at DOI: 10.1371/journal.ppat.0010026.st003 (29 KB DOC).
Text S1. PCR and Sequencing Errors
Found at DOI: 10.1371/journal.ppat.0010026.sd002 (19 KB DOC).
Text S2. Comparison of PoLV between Kiliﬁ Sequences and Isolate
3D7
Found at DOI: 10.1371/journal.ppat.0010026.sd003 (26 KB DOC).
Text S3. The Relationship between DBLa and ups
Found at DOI: 10.1371/journal.ppat.0010026.sd004 (20 KB DOC).
Text S4. Screening for Sequence Motifs Associated with DBLa
Sequence Length
Found at DOI: 10.1371/journal.ppat.0010026.sd005 (21 KB DOC).
Text S5. Sub-Classiﬁcation of DBLa Sequences by Their Sequence
Signatures
Found at DOI: 10.1371/journal.ppat.0010026.sd006 (21 KB DOC).
Text S6. var1 Genes
Found at DOI: 10.1371/journal.ppat.0010026.sd007 (23 KB DOC).
Accession Numbers
The EMBL Nucleotide Sequence Database (http://www.ebi.ac.uk/embl)
accession numbers discussed in this paper are cDNA (AM114937-
AM115658) and gDNA (AM115696-AM116719).
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